My Cannabis Reviews is reader-supported. If you buy through links on this page we may earn a commission, at no cost to you. It never changes what we write. How we review.
The short verdict
There is a bill in Congress that would wipe out the federal hemp rewrite entirely. It is called the Lawful Hemp Protection Act, it is bipartisan, and it does not merely delay the new definition of hemp the way September's stopgap did — it repeals the provision that created it and puts a different framework in its place.
It has also not moved an inch since the day it was introduced. As of 20 September 2026, the bill's most recent action on the official record is its own committee referral on 22 July. That is sixty days with no hearing, no markup and no vote, in any of the four committees it was sent to.
So the honest summary is this: H.R. 9830 is the shape a permanent fix would probably take if one ever arrives. It is not evidence that one is arriving. If you are deciding what to buy before the deadlines, plan around the law that exists, not around this.
And if you are here because you own or sell high-THCA hemp flower, read the section on the 1% threshold before you get your hopes up. This bill would not save it.
What the bill actually is
H.R. 9830, the Lawful Hemp Protection Act, was introduced on 22 July 2026 by Rep. Andy Barr (R-KY), with Rep. Angie Craig (D-MN) as original cosponsor. Craig is the Ranking Member — the senior Democrat — on the House Agriculture Committee, one of the four committees now holding the bill. That is a substantial name to have on it, but the minority's ranking member does not set a committee's hearing schedule; the chairman does, and the bill's record shows why that distinction matters. Its official title is "To preserve lawful hemp commerce while protecting consumers from high-THC synthetic intoxicants, and for other purposes."
The key structural fact, and the one most coverage gets soft on, is in Section 3. The bill does not postpone the hemp rewrite — it writes a new definition of hemp into the Agricultural Marketing Act of 1946, and then, under a heading reading "Conforming repeal", states that "Section 781 of the Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2026 (division B of Public Law 119–37) is repealed."
Section 781 is the provision that redefined hemp in the first place, and everything our federal hemp deadline tracker covers flows from it. H.R. 9830 would delete it outright and replace it.
The 1% threshold — and why it does not save THCA flower
Almost every write-up of this bill says it replaces the incoming 0.4 mg per-container limit with a "1% total THC" standard, and then stops. The detail that matters is how the 1% is measured, and the bill is specific about it.
The new definition covers the plant "and any part of that plant, including the seeds thereof and all naturally occurring derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers", with "a total tetrahydrocannabinol concentration (including tetrahydrocannabinol acid) of not more than 1 percent" — measured "on a dry weight basis."
Two things follow, and both are widely misreported.
First, this is not a finished-product standard. It is a dry-weight concentration test, structurally the same kind of test as today's 0.3% delta-9 rule, just with a higher ceiling and a broader set of compounds counted. Because the definition reaches derivatives and extracts "whether growing or not", it applies well past the field. Finished consumer products are handled separately, and we cover that below.
Second, THCA counts. The parenthetical "(including tetrahydrocannabinol acid)" puts THCA inside the calculation. High-THCA hemp flower — the product category built entirely on the fact that today's rule measures only delta-9 — typically tests somewhere between 15% and 30% THCA. A 1% ceiling that counts THCA does not come close to accommodating it.
This is worth being blunt about, because the question gets asked constantly and rarely answered from the statute. The bill the hemp industry would most like to see pass would, on THCA flower specifically, land in roughly the same place as the rewrite it repeals. It raises the ceiling from 0.3% to 1%, but it closes the loophole that made the category possible. If you want the background on why that distinction exists at all, our guide to THCA versus delta-9 THC covers the chemistry.
What would happen to finished products
Gummies, drinks, tinctures and vapes would not be judged by the 1% test. The bill adds a new Section 425 to the Federal Food, Drug, and Cosmetic Act that works in milligrams per serving instead.
It directs the Secretary — the Secretary of Health and Human Services, which in practice means the FDA; the bill's own section heading reads "FDA oversight and milligram limitations" — to set, within twelve months, "a maximum allowable amount of total cannabinoid content" for each product and each serving.
If that deadline is missed, statutory fallbacks kick in: 5 milligrams per serving for products taken orally, 50 milligrams per serving for inhalables, and 50 milligrams for topicals.
There is a drafting wrinkle worth noting for anyone reading the bill closely: the instruction to the Secretary is written in terms of total cannabinoid content, while the fallback limits that apply if the Secretary misses the deadline are written in terms of total tetrahydrocannabinol content. Those are not the same measurement, and which one governs would matter enormously to a CBD product with negligible THC.
Those fallback numbers deserve a moment. A 5 mg per-serving cap on edibles is below where a large part of the current market sits — plenty of the products in our best delta-9 gummies round-up are labelled at 10 mg or more per piece. A bill widely described as industry relief also contains, as its default setting, a limit that would reshape the edibles shelf. Whether that default ever applies depends entirely on whether the agency meets a twelve-month deadline.
That is not an idle question. The agency has already missed a deadline on exactly this subject. Under current law FDA was required to publish lists of covered cannabinoids and guidance defining "container" by 10 February 2026. As of today none of it exists — 222 days late. FDA has issued no 2026 Federal Register rulemaking directed at cannabinoids. Its only 2026 Federal Register discussion of delta-8 THC appears as a supporting example in the preamble to a proposed rule about something else — the 11 August 2026 GRAS proposed rule, Docket FDA-2025-N-3262 — and FDA's own cannabis page is still marked content-current as of July 2024. That proposed rule's comment period closes on 9 December 2026, two days before the hemp carve-out and government funding both expire.
Three taxes, not two — and a distribution system
The bill creates a new Chapter 56 in the Internal Revenue Code, and it is worth reading carefully because the usual summary — "a beverage tax and a 5% retail tax" — is wrong on both halves.
- Hemp beverages: "5 cents on each milligram of tetrahydrocannabinol in such beverage", paid by the manufacturer.
- Other hemp-derived cannabinoid products: 5 percent "of the price for which such product is sold". This is not a retail sales tax. The tax attaches when the product is "removed for consumption or sale" and is "paid by the manufacturer" — a manufacturer-level excise.
- Manufacturers themselves: a further 5 percent of "the sales revenue of such manufacturer for the taxable year".
Read together, a company making non-beverage hemp products would face a 5% excise on each sale and a 5% tax on annual gross receipts. Whether that survives contact with the Ways and Means Committee is a fair question — the wholesale trade group backing the bill has said publicly it wants more discussion on the tax rate.
Tucked into the same tax chapter is a provision we have not seen reported anywhere, and it may be the most commercially significant thing in the bill for the fastest-growing corner of the market. A new Section 5904 provides that "The Secretary shall prescribe regulations to establish and implement a three-tiered distribution system for hemp-derived beverages."
Three-tier is the structure American alcohol has run on since Prohibition ended: producers sell to licensed distributors, distributors sell to retailers, and the tiers are kept legally separate. Imposing it on hemp drinks would mean the brands currently shipping cans directly to customers could no longer do so — they would need a distributor in between. Because the section sits in the Internal Revenue Code rather than the food-and-drug title, the "Secretary" there reads as Treasury's rather than HHS's, which is a different agency from the one setting the milligram caps. It is an easy provision to miss, and we suspect that is exactly why it has been missed.
The rest of the bill, briefly
- 21 and over. The bill prohibits sale to anyone under 21 — and, unusually, also prohibits "the possession or consumption of a hemp-derived cannabinoid product by any person younger than 21 years of age."
- Made in America. A new FFDCA Section 301(jjj) would bar from interstate commerce any hemp-derived cannabinoid product "not derived exclusively from hemp cultivated in the United States, processed within the United States, and finished, packaged, and labeled within the United States." For brands sourcing overseas inputs, this is one of the most consequential lines in the bill and almost nobody is discussing it.
- Synthetics excluded by method. Cannabinoids "produced, manufactured, or converted using chemical synthesis, hydrogenation, acetylation, alkylation, or any other artificial process that adds to, removes from, or otherwise alters the molecular structure" fall outside the definition of hemp. HHC, THC-O-acetate and THCP are named in the text. Note the mechanism: they are not banned by a standalone prohibition, they are simply excluded from hemp — which leaves them to the Controlled Substances Act. Our cannabinoid glossary explains what each of these is.
- An industrial hemp category. Fiber, grain, seed, microgreens, research plants and non-intoxicating essential oils get their own defined lane, separate from consumables.
- Medicare Advantage. Section 5 would permit coverage of hemp-derived cannabinoid products as a special supplemental benefit for the chronically ill.
- Timing. The product-side changes would apply only to goods entering interstate commerce "on or after the date that is 180 days after the date of enactment", and the tax provisions are keyed to Treasury regulations due a year after enactment.
One thing you will not find in the bill: the words "delta-8" or "delta-9" appear nowhere in it. If you arrived looking for whether H.R. 9830 legalizes delta-8, the answer is that it does not address it by name at all — converted delta-8 would be governed by the "artificial process" exclusion above. For where converted delta-8 stands under the law that actually exists today, see our guide to which cannabinoids actually lose hemp status on 12 November and our deadline tracker, and for how the rules differ where you live, our state-by-state hemp THC guide.
The impaired-driving mandate nobody mentions
Every outlet lists the bill's four-committee referral. None explains the strange one. Why does the Transportation and Infrastructure Committee have a claim on a hemp bill that contains no transportation or shipping provision at all?
The answer is two provisions that have gone entirely unreported. Section 6(c) routes "amounts equivalent to 1 percent of the total taxes received in the Treasury each year" from the beverage tax into the Highway Trust Fund, earmarked for state enforcement, training and testing technology tied to "the zero-tolerance for impaired driving standards described in section 180 of title 23, United States Code."
There is no Section 180 in title 23 today. The numbers 181 through 190 were renumbered to 601 through 610 in 2005, and the slot has been empty since. The bill fills it itself: Section 9 adds a new "Section 180 — Zero tolerance for impaired driving" to the highway code, and enforces it the way Congress has enforced drinking-age and blood-alcohol standards for decades — by withholding money. The Secretary "shall withhold 10 percent" of a state's highway apportionment if that state does not have a conforming law in effect.
So a bill presented as hemp commerce legislation would also put a new impaired-driving mandate on all fifty states, backed by the threat of losing a tenth of their federal road funding. That is a significant policy commitment riding along inside a hemp bill, and it is the real reason a fourth committee is involved.
Where the bill actually stands
This is the part most coverage skips, and it is the part that should drive your decisions.
H.R. 9830 was referred on 22 July 2026 to four separate committees — Ways and Means, Energy and Commerce, Agriculture, and Transportation and Infrastructure — "for a period to be subsequently determined by the Speaker". As of 20 September 2026, the official record shows six actions on the bill, and all six are dated 22 July: the introduction and the referrals. Each of the four committees' own activity record for the bill consists of a single entry, "Referred To", dated 22 July. There has been no hearing, no markup and no committee vote.
The House Agriculture Committee — the full committee that holds the bill — does have a hearing on 16 September 2026, titled "Increasing Demand and Opportunities for Homegrown Products Here and Abroad". When we checked on 15 September 2026, the day before it was due to be held, no witness list had been posted on the committee's event page, in the House document repository, or on the Clerk's calendar, and neither the word "hemp" nor "cannabis" appeared anywhere in the hearing notice. As of 20 September the bill's official record is unchanged, so nothing that happened at that hearing has translated into recorded action on H.R. 9830. There is still nothing on the record connecting that hearing to this bill.
The bill has a sponsor and seven cosponsors, evenly split four Republicans and four Democrats counting Barr himself. They have arrived in bipartisan pairs — Reps. Moore (R-NC) and Veasey (D-TX) on 30 July, Reps. Evans (R-CO) and Gottheimer (D-NJ) on 20 August, and Reps. Baird (R-IN) and McCollum (D-MN) on 31 August. Reading that pattern, the sponsors appear to be protecting the bill's bipartisan balance deliberately as it grows. That is a reasonable thing to infer from the record; it is not a statement anyone has made on it.
A four-committee referral is a genuine obstacle, not a formality. Four chairmen would each have to find floor and hearing time for a bill that competes with everything else on their plates. And the industry is not united behind it: ATACH, which represents cannabis operators, opposes it on the grounds that it would "protect synthetic drugs."
The same members already tried a simpler fix in January
H.R. 9830 is not the first federal hemp fix this group has put its name to, and the earlier one is worth knowing about because almost nobody mentions it.
On 12 January 2026, Rep. James Baird (R-IN) — who joined H.R. 9830 as a cosponsor on 31 August — introduced H.R. 7010, a one-section bill with no short title. It would amend Section 781 by striking "365 days" and inserting "3 years": a three-year runway for the hemp rewrite instead of one, with no repeal and no replacement framework. Its four cosponsors, all added the day it was introduced, were Reps. James Comer (R-KY), Gabe Evans (R-CO), Tim Moore (R-NC) and Angie Craig (D-MN).
Line the two rosters up and four of the eight members behind H.R. 9830 — Baird, Craig, Evans and Moore — were already on H.R. 7010 seven months earlier. Reading the record, the same bipartisan group has now tried both a plain delay and a full replacement. That is our inference from the two sponsor lists; none of them has said it.
H.R. 7010 was referred to the House Agriculture Committee on 12 January and to its Subcommittee on Forestry and Horticulture on 20 May 2026, and as of 20 September that referral is the last action on it. It has had no hearing either. It is not law, and neither bill's delay would have any bearing on the dates that are: the one-month narrowing in Public Law 119-103 came from a stopgap funding bill, not from either of these.
How this fits with the 11 December deadline
Keep two bills separate, because conflating them is the single most common error in coverage of this subject.
H.R. 6500 is the continuing resolution signed on 2 September 2026, now on the books as Public Law 119-103. Its Section 2019 is what narrowed the reach of the hemp rewrite until 11 December 2026. That one is law.
H.R. 9830 is this bill. It is not law and has had no action since July.
The connection between them is timing. Government funding runs out on 11 December 2026 — the same day the hemp carve-out expires. Whatever Congress passes to keep the lights on is the obvious vehicle for any hemp language, which is why the industry's attention will be on December rather than on the four committees. But an obvious vehicle is not a scheduled one, and nobody should be told otherwise. Our federal hemp deadline tracker follows the dates that are actually law, and is the page to watch.
What this means if you are buying
Nothing about H.R. 9830 changes what is legal today or what will be legal in November and December. It is a proposal sitting in committee.
The practical advice is unchanged from our deadline coverage: buy from brands that publish current, batch-specific lab reports, and check them. If you are not sure what you are looking at, our guide to reading a certificate of analysis walks through it. When federal categories are this unsettled, third-party testing is the only part of the picture you can actually verify yourself — which is the same reason it carries the most weight in our brand rankings.
FAQ
Would H.R. 9830 repeal the hemp ban?
It would repeal Section 781, the provision that rewrote the federal definition of hemp, and replace it with a different framework. But it has had no committee action since 22 July 2026, so as of 20 September it is a proposal and nothing more.
Would it make THCA flower legal again?
No. Its 1% ceiling expressly includes THCA, and high-THCA flower typically tests far above 1%. On this specific question the bill lands close to the rewrite it would repeal.
Is it Trump-backed?
We would not describe it that way. There is an April 2026 statement from the President about continued access to full-spectrum CBD products, but that is not an endorsement of a bill introduced in July, and we have seen no White House position on H.R. 9830 itself.
Does it legalize delta-8?
The bill never mentions delta-8. Cannabinoids made by chemical conversion would be excluded from the definition of hemp under its "artificial process" language.
Would it change how hemp drinks are sold?
Yes, and this is one of the least-discussed parts of the bill. It directs regulators to build a three-tiered distribution system for hemp beverages — the same producer-distributor-retailer structure alcohol uses — which would mean hemp drink brands could no longer ship directly to customers.
When would it take effect if it passed?
The product-side changes would apply to goods entering interstate commerce 180 days after enactment, and the tax provisions are tied to Treasury regulations due within a year. Since the bill has not had a hearing, any timeline is hypothetical.
What should I actually watch?
The 11 December 2026 funding deadline, because it is the same day the current hemp carve-out expires and the likeliest vehicle for any hemp legislation.
Sources and how we checked
Bill text and status are taken from the Government Publishing Office's official record for H.R. 9830 and H.R. 7010 — the bill status files, re-read on 20 September 2026, and the introduced-in-House bill texts — rather than from summaries. Quoted language is from that text. The public law number for H.R. 6500 is from the Office of the Federal Register's own listing of current public laws. The current state of title 23 was checked against the official United States Code. The status of FDA's overdue cannabinoid lists was checked against the Federal Register and FDA's own cannabis page. All claims on this page are current as of 20 September 2026; the bill's cosponsor list changes, and we re-check it on each update. Rep. Craig's committee position is from the House Agriculture Committee's own published membership for the 119th Congress.
This page is general information, not legal advice. Hemp law is changing quickly and varies by state — check your own state's rules before buying or travelling with any hemp product.
Affiliate disclosure: some links on this page earn us a commission if you buy. We never accept payment for a rating or a ranking.
